GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Clinical trials for GASTROESOPHAGEAL REFLUX DISEASE (GERD) explained in plain language.
Never miss a new study
Get alerted when new GASTROESOPHAGEAL REFLUX DISEASE (GERD) trials appear
Sign up with your email to follow new studies for GASTROESOPHAGEAL REFLUX DISEASE (GERD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for heartburn sufferers: study tests combo therapy for NERD
Disease control OngoingThis study is testing a new combination treatment for non-erosive reflux disease (NERD), a common form of GERD that causes heartburn and other symptoms. The treatment adds therapies to strengthen the esophagus's natural barrier on top of standard acid-reducing medication. Researc…
Matched conditions: GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Sponsor: I.M. Sechenov First Moscow State Medical University • Aim: Disease control
Last updated Jun 26, 2026 18:27 UTC
-
New hope for kids with heartburn: study tests daily pill
Symptom relief OngoingThis study tests whether a daily medicine called dexlansoprazole can safely reduce symptoms of gastroesophageal reflux disease (GERD) in children aged 2 to 11 years who have heartburn but no damage to their esophagus. About 71 children will take the medicine or a placebo for 12 w…
Matched conditions: GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Phase: PHASE2 • Sponsor: Takeda • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC